This would mean that following SARS-CoV-2 infection, increased PD-1 pathway activity persists for many weeks, regardless of whether the child is healthy or has JIA diagnosed and, in the case of JIA, regardless of whether the disease is active. The gene discussed is PDCD1; the disease is juvenile idiopathic arthritis.